BamSEC and AlphaSense Join Forces
Learn More

Mosaic ImmunoEngineering

OTC: CPMV    
Share price (12/30/24): $0.70    
Market cap (12/30/24): $5.075 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 1 page Employee Status Change
12/34/56
EX-10.2
from 10-Q 11 pages Note Purchase Agreement
12/34/56
EX-10.1
from 8-K 4 pages This Letter, Together With the Attached Binding Term Sheet Attached Hereto, Sets Forth Our Mutual Understanding Regarding a Possible Commercial Relationship Referred to as the “Transaction” Between Mosaic Immunoengineering, Inc., a Delaware Corporation (“Mosaic”) and Oncotelic Therapeutics, Inc., a Delaware Corporation (“Oncotelic”). It Is Understood That Any Such Transaction Is Subject to Our Mutual Agreement on Terms Through a Definitive Document Entered Into by Mosaic and Oncotelic Formalizing the Transaction
12/34/56
EX-10.1
from 8-K 2 pages Amendment No. 1 to Series a Preferred Stock Redemption Agreement
12/34/56
EX-10.1
from 10-Q 26 pages Certain Information in This Document, Marked by [**], Has Been Excluded Pursuant to Regulation S-K, Item 601(b)(10)(iv). Such Excluded Information Is Not Material and Is the Type That the Registrant Treats as Private or Confidential License Agreement Case Western Reserve University – Mosaic Immunoengineering, Inc
12/34/56
EX-10.1
from 8-K 3 pages Series a Preferred Stock Redemption Agreement
12/34/56
EX-10.1
from 8-K 22 pages Form of Convertible Note Purchase Agreement
12/34/56
EX-10.1
from 8-K 19 pages Form of Convertible Note Purchase Agreement
12/34/56
EX-10.1
from 10-Q 10 pages Mosaic ImmunoEngineering Inc. Consulting Agreement
12/34/56
EX-10.11
from 10-KT 12 pages Form of Indemnification Agreement
12/34/56
EX-10.10
from 10-KT 4 pages Mosaic ImmunoEngineering Inc. 2020 Omnibus Incentive Plan Notice of Stock Appreciation Rights
12/34/56
EX-10.9
from 10-KT 5 pages Mosaic ImmunoEngineering Inc. 2020 Omnibus Incentive Plan Notice of Restricted Stock Units
12/34/56
EX-10.8
from 10-KT 4 pages Mosaic ImmunoEngineering Inc. 2020 Omnibus Incentive Plan Notice of Restricted Stock
12/34/56
EX-10.7
from 10-KT 5 pages Mosaic ImmunoEngineering Inc. 2020 Omnibus Incentive Plan Notice of Non-Qualified Stock Option
12/34/56
EX-10.6
from 10-KT 5 pages Mosaic ImmunoEngineering Inc. 2020 Omnibus Incentive Plan Notice of Incentive Stock Option
12/34/56
EX-10.5
from 10-KT 16 pages Mosaic ImmunoEngineering Inc. Code of Business Conduct and Ethics Adopted November 3, 2020
12/34/56
EX-10.4
from 10-Q 2 pages Offer Letter - Paul Lytle
12/34/56
EX-10.3
from 10-Q 2 pages Offer Letter - Steven King
12/34/56
EX-10.1
from 8-K 2 pages Patriot Scientific Corporation Announces Name Change to “Mosaic Immunoengineering Inc.”, Stock Symbol Change and Reverse Stock Split
12/34/56
EX-10.14
from 10-Q 13 pages Materials Transfer, Evaluation and Exclusive Option Agreement
12/34/56